NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 67 filers reported holding NURIX THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $474,099 | +31.3% | 60,318 | +48.4% | 0.00% | – |
| Q1 2023 | $360,963 | +45.0% | 40,649 | +79.1% | 0.00% | – |
| Q4 2022 | $249,000 | -95.8% | 22,700 | -89.9% | 0.00% | -100.0% |
| Q2 2021 | $5,960,000 | -12.7% | 224,686 | +2.3% | 0.00% | 0.0% |
| Q1 2021 | $6,828,000 | +61.2% | 219,621 | +70.5% | 0.00% | 0.0% |
| Q4 2020 | $4,236,000 | -52.5% | 128,800 | -49.5% | 0.00% | -50.0% |
| Q3 2020 | $8,911,000 | – | 255,248 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 15,823 | $163,293 | 0.00% |